Comment
doi: 10.1016/S1473-3099(15)70108-8.
Epub 2015 Apr 12.
Lower-dose efavirenz: what is needed before implementation?
Affiliations
- PMID: 25877960
- DOI: 10.1016/S1473-3099(15)70108-8
Item in Clipboard
Comment
Lower-dose efavirenz: what is needed before implementation?
Lancet Infect Dis.
2015 Jul.
No abstract available
Comment on
-
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.Lancet Infect Dis. 2015 Jul;15(7):793-802. doi: 10.1016/S1473-3099(15)70060-5. Epub 2015 Apr 12. Lancet Infect Dis. 2015. PMID: 25877963 Clinical Trial.
Similar articles
-
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.Lancet Infect Dis. 2015 Jul;15(7):793-802. doi: 10.1016/S1473-3099(15)70060-5. Epub 2015 Apr 12. Lancet Infect Dis. 2015. PMID: 25877963 Clinical Trial.
-
Raltegravir as effective as efavirenz in 144-week data.AIDS Patient Care STDS. 2009 Aug;23(8):679-80. AIDS Patient Care STDS. 2009. PMID: 19694035 Clinical Trial. No abstract available.
-
PharmGKB summary: Efavirenz pathway, pharmacokinetics.Pharmacogenet Genomics. 2015 Jul;25(7):363-76. doi: 10.1097/FPC.0000000000000145. Pharmacogenet Genomics. 2015. PMID: 25966836 Free PMC article. Review. No abstract available.
-
Elvucitabine data released at CROI.AIDS Patient Care STDS. 2010 Mar;24(3):198. AIDS Patient Care STDS. 2010. PMID: 20235383 No abstract available.
-
Neuropsychiatric symptoms associated with efavirenz: prevalence, correlates, and management. A neurobehavioral review.AIDS Rev. 2009 Apr-Jun;11(2):103-9. AIDS Rev. 2009. PMID: 19529750 Review.
Cited by
-
A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women.Clin Pharmacokinet. 2018 Nov;57(11):1421-1433. doi: 10.1007/s40262-018-0642-9. Clin Pharmacokinet. 2018. PMID: 29520730 Free PMC article.
-
Evaluation of universal versus genotype-guided efavirenz dose reduction in pregnant women using population pharmacokinetic modelling.J Antimicrob Chemother. 2018 Jan 1;73(1):165-172. doi: 10.1093/jac/dkx334. J Antimicrob Chemother. 2018. PMID: 29029267 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
